Related Experiment Video
Updated: Apr 8, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.5K
A literature review: polypharmacy protocol for primary care
1University of Kentucky, College of Nursing, USA; University of Louisville, School of Nursing, USA.
Summary
No standardized protocol exists for managing polypharmacy in older adults within primary care. Developing and evaluating such a protocol is crucial to reduce adverse drug events and improve patient outcomes.
Area of Science:
- Geriatric Medicine
- Clinical Pharmacy
- Health Services Research
Background:
- Polypharmacy, the use of multiple medications, is prevalent in older adults (65+).
- It poses significant risks, including adverse drug events (ADEs), falls, hospitalizations, and increased healthcare costs.
- Current primary care practices lack a standardized protocol for managing polypharmacy in this demographic.
Purpose of the Study:
- To critically evaluate existing literature on polypharmacy protocols for adults aged 65 and older in primary care.
- To identify potential strategies for reducing ADEs associated with polypharmacy.
- To highlight the need for a standardized protocol in primary care settings.
Main Methods:
- A comprehensive literature review of OVID, CINAHL, EBSCO, Cochrane Library, Medline, and PubMed databases.
- Keywords included: protocol, guideline, geriatrics, elderly, older adult, polypharmacy, and primary care.
- Inclusion criteria focused on interventions, protocols, or guidelines addressing polypharmacy and reducing ADEs, published after 1992. Qualitative and quantitative studies were considered.
Main Results:
- A significant gap exists in the literature regarding standardized polypharmacy protocols for primary care.
- Various strategies, mnemonics, algorithms, and guidelines were identified but not integrated into a cohesive primary care protocol.
- Screening tools like Beers Criteria and STOPP were found but not part of a standardized management protocol.
Conclusions:
- There is a critical need for a standardized protocol to manage polypharmacy in the elderly within primary care.
- Such a protocol could mitigate risks like falls and hospitalizations.
- Further research should focus on developing and evaluating standardized protocols to improve patient outcomes in geriatric polypharmacy.
Related Concept Videos
Drug Dosing: Geriatric Patients
358
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
358
Dosage Regimens: Partial Pharmacokinetic Parameters
268
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
268
Dosage Regimens: Designs and Approaches
483
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
483
Coronary Artery Disease V: Interprofessional Care
419
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
419
Primary Healthcare Services
2.7K
Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
2.7K
Drug Dosage Regimen: Overview
4.7K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
4.7K

